Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199

PLoS ONE - United States
doi 10.1371/journal.pone.0152607
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

BCL-xL-Inhibitory BH3 Mimetics (ABT-737 or ABT-263) and the Modulation of Cytosolic Calcium Flux and Platelet Function

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

ABT-263 and Rapamycin Act Cooperatively to Kill Lymphoma Cells in Vitro and in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Comparison of Putative BH3 Mimetics AT-101, HA14-1, Sabutoclax and TW-37 With ABT-737 in Platelets

Platelets
MedicineHematology
2020English

Human Testis–Derived Pluripotent Cells and Induced Pluripotent Stem Cells

2013English

ABT-263 Induces G1/G0-Phase Arrest, Apoptosis and Autophagy in Human Esophageal Cancer Cells in Vitro

Acta Pharmacologica Sinica
MedicinePharmacology
2017English

Synergistic Killing of Human Small Cell Lung Cancer Cells by the BCL-2-Inositol 1,4,5-Trisphosphate Receptor Disruptor BIRD-2 and the BH3-mimetic ABT-263

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2015English

Selective Elimination of Culture-Adapted Human Embryonic Stem Cells With BH3 Mimetics

Stem Cell Reports
BiochemistryGeneticsDevelopmental BiologyCell Biology
2018English

Preclinical Evaluation of Antiangiogenic Thrombospondin-1 Peptide Mimetics, ABT-526 and ABT-510, in Companion Dogs With Naturally Occurring Cancers

Clinical Cancer Research
Cancer ResearchOncology
2006English

Norcantharidin Enhances ABT-263-mediated Anticancer Activity in Neuroblastoma Cells by Upregulation of Noxa

Oncology Reports
MedicineCancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy